.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
It’s unclear how many staff at the FDA have been affected. There have also been ...
“While the EIS program has likely been spared this time, the fact that its exist...
The former head of the FDA's food division told STAT he resigned because cuts ma...
While Exelixis has abandoned a plan to seek an FDA approval for a combination of...
Lawsuit claims UK pharma giant understated the risk of government investigations
Former CDC Director Tom Frieden warns that cutting the Public Health Associate P...
TUESDAY, Feb. 18, 2025 -- Serum testosterone (T) recovery to normal levels is a...
TUESDAY, Feb. 18, 2025 -- For patients with advanced prostate cancer (aPC), com...
TUESDAY, Feb. 18, 2025 -- For patients with acute ischemic stroke (AIS) whose s...
TUESDAY, Feb. 18, 2025 -- A "Man Van" deployed in disadvantaged communities can...
TUESDAY, Feb. 18, 2025 -- For patients with large vessel occlusion presenting b...
TUESDAY, Feb. 18, 2025 -- There was a notable decrease in common ophthalmic pro...
TUESDAY, Feb. 18, 2025 -- The U.S. Food and Drug Administration has approved a ...
TUESDAY, Feb. 18, 2025 -- In a clinical report issued by the American Academy o...
In exchange for $165 million, Biogen now has access to zorevunersen, a potential...
The FDA has given a thumbs up to Sanofi’s Merilog as the first biosimilar substi...
The company raised $200 million after early findings hinted its therapy could be...
Uganda discharged on Tuesday the last eight patients who recovered from Ebola, a...
The National Institutes of Health has lost two distinguished leaders as mass lay...
Human medicines European public assessment report (EPAR): Ravicti, glycerol phen...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
J&J said it found no immediate procedure-related causes from the atrial fibrilla...
Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Da...
Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel...